RxISK

Making Medicines Safer for All of Us

Drug Search by Year (Detail)

Side effect search by year (detail)

Drug:

Reaction: DISEASE PROGRESSION

20250101 - 20251231

No. 1 - 100

Next page: 2 next page>>
No.
safetyreportid
occurcountry
patientonsetage
patientsex 1:M 2:F
Adverse reaction
Drug (openfda.generic_name, medicinalproduct)
1
25139054
EG
 2
Disease progression,
ADO-TRASTUZUMAB EMTANSINE,
2
25139206
TW
 68 2
Pulmonary mass, Disease progression, Metastases to lung, Metastases to pleura, Soft tissue neoplasm, Metastases to liver, Off label use,
ERLOTINIB HYDROCHLORIDE, ATEZOLIZUMAB, BEVACIZUMAB, PACLITAXEL,
3
25139392
CH
 1
Disease progression,
GLOFITAMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE,
4
25139643
US
 1
Disease progression,
PIMAVANSERIN TARTRATE,
5
25139983
CA
 2
Neovascular age-related macular degeneration, Disease progression,
RANIBIZUMAB,
6
25140045
AT
 2
Disease progression,
7
25140222
IT
 2
Disease progression, Diffuse large B-cell lymphoma refractory,
LENALIDOMIDE, LONCASTUXIMAB TESIRINE,
8
25140260
US
 107 1
Disease progression, Drug ineffective, Myelosuppression, Febrile neutropenia, Infection,
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, ETOPOSIDE,
9
25140333
FI
 60 1
Disease progression, Hepatic failure, Neutropenia,
IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM, FLUOROURACIL,
10
25140357
JP
 12 1
Dermatomyositis, Disease progression, Off label use, Product use in unapproved indication,
CYCLOSPORINE, METHOTREXATE, METHOTREXATE SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, METHYLPREDNISOLONE,
11
25140590
CZ
 44 2
Metastases to liver, Disease progression, Neutropenia, Abdominal pain, Diarrhoea,
SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, DENOSUMAB,
12
25140664
JP
 7 2
Disease progression,
AXICABTAGENE CILOLEUCEL,
13
25140691
DE
 60 2
Disease progression,
AXICABTAGENE CILOLEUCEL,
14
25142015
GR
 45 2
Metastases to thyroid, Disease progression,
OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, FLUOROURACIL, FLUOROURACIL, FLUOROURACIL, FLUOROURACIL, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB,
15
25142170
CN
Disease progression,
DURVALUMAB,
16
25142236
PL
 45
Anaphylactic shock, Leukopenia, Thrombocytopenia, Acetabulum fracture, Neutropenia, Disease progression, Splenomegaly,
PREDNISONE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, CISPLATIN, RITUXIMAB, MOSUNETUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, ETOPOSIDE, ETOPOSIDE, METHYLPREDNISOLONE, CYTARABINE, IFOSFAMIDE, LENALIDOMIDE, CARBOPLATIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BENDAMUSTINE HCL,
17
25138500
US
Disease progression, Off label use,
ISATUXIMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CARFILZOMIB, CARFILZOMIB,
18
25138519
LB
Off label use, Disease progression,
ATEZOLIZUMAB, CARBOPLATIN, BEVACIZUMAB, PACLITAXEL,
19
25137187
PK
 72 1
Disease progression,
RITUXIMAB,
20
25137394
AU
 51 1
Dyspnoea, Chest pain, Coma scale abnormal, Diarrhoea, Disease progression, Microsporidia infection, Pneumocystis jirovecii infection, Therapeutic product effect incomplete,
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, NITAZOXANIDE, ALLOPURINOL, AMLODIPINE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CANDESARTAN CILEXETIL, CARVEDILOL, CEFTRIAXONE, CEFTRIAXONE SODIUM, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, FUROSEMIDE, HYDRALAZINE HYDROCHLORIDE, PRAVASTATIN SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, VORICONAZOLE, INSULIN ASPART, SEMAGLUTIDE, EVEROLIMUS, EVEROLIMUS TABLETS, NICOTINAMIDE,
21
25137518
CN
 40 2
Disease progression, Drug ineffective,
BEVACIZUMAB, BEVACIZUMAB,
22
25137787
AU
 51 1
Chest pain, Pneumocystis jirovecii infection, Coma scale abnormal, Diarrhoea, Disease progression, Dyspnoea, Microsporidia infection, Therapeutic product effect incomplete,
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, INSULIN ASPART, NITAZOXANIDE, SEMAGLUTIDE, ALLOPURINOL, AMLODIPINE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CANDESARTAN CILEXETIL, CARVEDILOL, CEFTRIAXONE SODIUM, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, EVEROLIMUS, EVEROLIMUS TABLETS, FUROSEMIDE, HYDRALAZINE HYDROCHLORIDE, NICOTINAMIDE, PRAVASTATIN SODIUM, VORICONAZOLE,
23
25137850
AU
 51 1
Diarrhoea, Pneumocystis jirovecii infection, Chest pain, Coma scale abnormal, Disease progression, Dyspnoea, Microsporidia infection, Therapeutic product effect incomplete,
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, INSULIN ASPART, NITAZOXANIDE, ALLOPURINOL, AMLODIPINE BESYLATE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CANDESARTAN CILEXETIL, CARVEDILOL, CEFTRIAXONE SODIUM, CLINDAMYCIN HYDROCHLORIDE, EVEROLIMUS, EVEROLIMUS TABLETS, FUROSEMIDE, HYDRALAZINE HYDROCHLORIDE, NICOTINAMIDE, PRAVASTATIN SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, VORICONAZOLE, SEMAGLUTIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION,
24
25137941
US
 67 1
Arrhythmic storm, Disease progression, Drug ineffective for unapproved indication,
METOPROLOL TARTRATE, METOPROLOL, SOTALOL HYDROCHLORIDE,
25
25138024
PK
 56 2
Disease progression,
ATEZOLIZUMAB,
26
25138064
PK
 42 2
Disease progression,
TRASTUZUMAB,
27
25132238
PK
 63 2
Disease progression,
TRASTUZUMAB,
28
25132309
PK
 64 2
Disease progression,
PERTUZUMAB, TRASTUZUMAB,
29
25132331
US
Disease progression, Drug intolerance, Drug ineffective,
BEVACIZUMAB,
30
25132383
AT
Disease progression,
RITUXIMAB, GLOFITAMAB, OBINUTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, LENALIDOMIDE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, VINCRISTINE SULFATE,
31
25132537
AU
Disease progression, Therapeutic response decreased,
ATEZOLIZUMAB, BEVACIZUMAB, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM,
32
25132659
PK
 76 2
Disease progression,
TRASTUZUMAB, PERTUZUMAB,
33
25132736
FR
 47
Disease progression,
GLOFITAMAB,
34
25133099
IE
Disease progression,
RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, BENDAMUSTINE HCL, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CISPLATIN,
35
25133529
PL
 40 1
Cutaneous T-cell lymphoma stage I, Disease progression, Multiple organ dysfunction syndrome,
FUROSEMIDE, FILGRASTIM, ALLOPURINOL, BEXAROTENE, CALCIUM CARBONATE, MEROPENEM, MORPHINE, PEGINTERFERON ALFA-2A, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, RASBURICASE, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, FILGRASTIM,
36
25133610
CN
 50 1
Disease progression,
ATEZOLIZUMAB,
37
25133643
AT
Cytopenia, Meningitis, Disease progression,
DARATUMUMAB,
38
25133705
CN
 67 1
Facial paralysis, Cerebral infarction, Disease progression, Bedridden, Eating disorder,
GLOFITAMAB,
39
25133852
KW
Disease progression, Hypothyroidism, Hepatic lesion,
BEVACIZUMAB, ATEZOLIZUMAB,
40
25133870
US
 1
Pneumonia, Disease progression,
EDARAVONE, EDARAVONE,
41
25134029
PK
 66 2
Disease progression,
BEVACIZUMAB,
42
25134239
GB
 66 1
Disease progression, Immunoglobulin G4 related disease,
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM,
43
25134246
CN
 1
Disease progression,
TOBRAMYCIN, TOBRAMYCIN SULFATE, TOBRAMYCIN SOLUTION,
44
25134286
GB
 73 1
Endocarditis, Disease progression,
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CISPLATIN,
45
25134505
GB
 73 1
Endocarditis, Disease progression,
CISPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, PREDNISONE, RITUXIMAB, VINCRISTINE SULFATE,
46
25134516
US
 1
Duchenne muscular dystrophy, Disease progression, Coma, Cardio-respiratory arrest, Brain oedema, Heart rate irregular, Dyspnoea,
VAMOROLONE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, HYDROXYZINE, HYDROXYZINE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, SACUBITRIL AND VALSARTAN,
47
25134745
RU
 72 1
Myocardial ischaemia, Angina pectoris, Essential hypertension, Dermatitis, Respiratory tract infection viral, Acute coronary syndrome, Atrioventricular block, Sepsis, Urticaria, Hypertensive crisis, Skin lesion, Disease progression, Anaemia, Hypertension,
ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS,
48
25134808
PK
 36 2
Disease progression,
TRASTUZUMAB, PERTUZUMAB,
49
25135145
GB
 2
Disease progression,
SACITUZUMAB GOVITECAN,
50
25135157
US
Disease progression,
OSIMERTINIB,
51
25135204
US
Disease progression,
GEFITINIB,
52
25135467
Cytopenia, Disease progression,
RUXOLITINIB, CYCLOSPORINE, PREDNISONE, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, CAPTOPRIL, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE,
53
25135518
PL
 73 2
Upper respiratory tract infection, Inflammatory marker increased, Pneumonia, Disease progression, Neutropenia, Chronic obstructive pulmonary disease,
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, LENALIDOMIDE, MOSUNETUZUMAB, PREDNISONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB,
54
25135638
US
Disease progression,
DURVALUMAB, CARBOPLATIN, TREMELIMUMAB,
55
25135644
CN
 58 1
Mouth ulceration, Dermatitis acneiform, Pruritus, Disease progression,
BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, AFATINIB, ACARBOSE, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, CISPLATIN, CISPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS,
56
25135882
IT
 2
Death, Disease progression, Neoplasm recurrence, Pain, Weight decreased, Medication error,
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, DURVALUMAB, TREMELIMUMAB, CARBOPLATIN,
57
25136017
JP
 75
Disease progression, Central nervous system leukaemia,
BLINATUMOMAB,
58
25136463
ES
 38 2
Enterococcal infection, Meningitis, Drug ineffective, Disease progression,
PREDNISONE, DOXORUBICIN, ETOPOSIDE, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, IFOSFAMIDE, CISPLATIN, CYTARABINE,
59
25126457
ES
Disease progression, Herpes simplex reactivation, Giardiasis, Malignant syphilis, Enteritis infectious, Drug ineffective, Intentional product use issue, Product use in unapproved indication,
RITUXIMAB, RITUXIMAB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, IBRUTINIB, IBRUTINIB,
60
25126590
PK
 57 2
Disease progression,
BEVACIZUMAB,
61
25126623
PK
 63
Disease progression,
BEVACIZUMAB, ATEZOLIZUMAB,
62
25126640
PK
 68 1
Disease progression,
BEVACIZUMAB, ATEZOLIZUMAB,
63
25127215
PK
 29 1
Disease progression, Drug ineffective,
POLATUZUMAB VEDOTIN,
64
25127557
CN
 2
Pyrexia, Disease progression, Pneumonia, Cough, Marasmus, Anaemia, Gastritis, Renal failure, Hepatic failure, Nausea, Vomiting, Hyperuricaemia, Pleural effusion, Cachexia, Death, Nasopharyngitis, Oedema, Biliary dilatation, Ascites, Vascular compression, Atelectasis, Pelvic fluid collection, Intra-abdominal fluid collection, Staphylococcus test positive, Pancreatic duct dilatation, Venous stenosis, Electrolyte imbalance,
CYCLOSPORINE,
65
25127764
AU
Disease progression, Therapeutic response decreased, Toxicity to various agents,
BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB,
66
25127813
US
 1
Disease progression,
ENFORTUMAB VEDOTIN,
67
25127904
IL
Disease progression, Brain radiation necrosis, Off label use,
BEVACIZUMAB,
68
25127924
BE
 1
Disease progression,
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,
69
25128128
US
Disease progression,
OSIMERTINIB,
70
25128140
IN
Disease progression,
ENTRECTINIB,
71
25128361
CZ
 2
Disease progression,
SACITUZUMAB GOVITECAN,
72
25128544
IT
 57 1
Disease progression, Therapeutic product effect incomplete, Paraesthesia, Asthenia, Dyspnoea, Cough, Wheezing,
CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PACLITAXEL,
73
25128587
US
Disease progression,
DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT), BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG,
74
25128676
PK
 81 2
Disease progression,
75
25128846
LT
 33 2
Condition aggravated, Disease progression, Drug ineffective for unapproved indication, Off label use,
METHOTREXATE, METHOTREXATE SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, AZATHIOPRINE, PENTOXIFYLLINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PENICILLAMINE, ALPROSTADIL, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION,
76
25129448
US
Disease progression,
OSIMERTINIB, DATOPOTAMAB DERUXTECAN,
77
25131017
PL
 45
Acetabulum fracture, Anaphylactic shock, Disease progression, Splenomegaly, Leukopenia, Neutropenia, Thrombocytopenia,
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, RITUXIMAB, MOSUNETUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, ETOPOSIDE, ETOPOSIDE, METHYLPREDNISOLONE, CYTARABINE, CISPLATIN, IFOSFAMIDE, CARBOPLATIN, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BENDAMUSTINE HCL, LENALIDOMIDE,
78
25131411
GB
 2
Disease progression,
DABRAFENIB, TRAMETINIB,
79
25120947
US
 1
Dependence on oxygen therapy, Disease progression,
IPRATROPIUM BROMIDE AND ALBUTEROL,
80
25121512
US
 59 1
Disease progression, Drug ineffective,
DOXORUBICIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB, RITUXIMAB,
81
25121516
US
 52 1
Disease progression,
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BORTEZOMIB, BORTEZOMIB, CARFILZOMIB, CARFILZOMIB, CARFILZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DARATUMUMAB, IXAZOMIB, LENALIDOMIDE, LENALIDOMIDE, MELPHALAN, MELPHALAN HYDROCHLORIDE,
82
25121580
RU
 75 2
Disease progression, Polyneuropathy,
PERTUZUMAB, TRASTUZUMAB, ADO-TRASTUZUMAB EMTANSINE, PACLITAXEL,
83
25121675
US
Disease progression,
RIPRETINIB,
84
25121703
CH
Disease progression,
SACITUZUMAB GOVITECAN,
85
25121725
IN
 58 1
Off label use, Haemoglobin decreased, Hypertension, Death, Disease progression, Gene mutation, Paralysis, Drug ineffective, Cerebral infarction, Multiple organ dysfunction syndrome, Lung cancer metastatic, Ascites, Anaphylactic reaction, Ascites, Weight decreased,
ATEZOLIZUMAB, ATEZOLIZUMAB, CARBOPLATIN,
86
25122150
LB
Disease progression,
ATEZOLIZUMAB,
87
25122725
PL
 59 1
Neuropathy peripheral, Diabetes mellitus, Thyroid disorder, Disease progression, Asthenia,
AVELUMAB,
88
25122899
US
 65 2
Disease progression,
ERLOTINIB HYDROCHLORIDE, ERLOTINIB, OSIMERTINIB,
89
25123784
FR
 63 2
Disease progression,
LENALIDOMIDE,
90
25123794
JP
 75 1
Disease progression, Drug ineffective,
OXALIPLATIN, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, REGORAFENIB,
91
25123799
CN
 18 1
Disease progression,
TEMOZOLOMIDE, BEVACIZUMAB, PACLITAXEL,
92
25123808
US
 37 1
Histoplasmosis disseminated, Serratia bacteraemia, Klebsiella bacteraemia, Drug ineffective, Disease progression,
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, AMPICILLIN SODIUM AND SULBACTAM SODIUM,
93
25123811
US
 3 2
Streptococcal infection, Candida infection, Septic pulmonary embolism, Lemierre syndrome, Treatment failure, Disease progression, Off label use,
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, CYCLOBENZAPRINE,
94
25123823
FR
 7 1
Disease progression, Dyspnoea,
CLOBAZAM, TOPIRAMATE, TOPIRAMATE SPINKLE, MIGLUSTAT,
95
25124287
AU
 2
Disease progression,
AXICABTAGENE CILOLEUCEL,
96
25125084
FR
 2
Lung disorder, Pleural effusion, Disease progression,
FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI,
97
25125851
CA
 29 1
Hyperferritinaemia, Pancytopenia, Lymphadenopathy, Splenomegaly, Hypofibrinogenaemia, Disease progression, Haemophagocytic lymphohistiocytosis, Pyrexia, Therapy non-responder, Product use in unapproved indication,
CYCLOSPORINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ELTROMBOPAG, ETOPOSIDE, ANAKINRA, HUMAN IMMUNOGLOBULIN G, TOCILIZUMAB, PREDNISONE,
98
25126192
JP
 2
Disease progression,
IMIGLUCERASE,
99
25128497
77 1
Disease progression,
OSIMERTINIB,
100
25115677
GB
 1
Renal impairment, Hypokalaemia, Disease progression,
AMPHOTERICIN B, AMPHOTERICIN B, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, AMPHOTERICIN B,

disclaimer

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.

terms

https://open.fda.gov/terms/

license

https://open.fda.gov/license/

last_updated

2025-04-28

Next page: 2 next page>>